High-Flow Nasal Cannula versus Noninvasive Positive Pressure Ventilation in Patients with Heart Failure after Extubation: An Observational Cohort Study
- Resource Type
- article
- Authors
- Che-Jung Chang; Ling-Ling Chiang; Kuan-Yuan Chen; Po-Hao Feng; Chien-Ling Su; Han-Shui Hsu
- Source
- Canadian Respiratory Journal, Vol 2020 (2020)
- Subject
- Diseases of the respiratory system
RC705-779
- Language
- English
- ISSN
- 1198-2241
1916-7245
Noninvasive positive pressure ventilation (NPPV) has been widely applied in patients with high-risk extubation failure, including heart failure. High-flow nasal cannula (HFNC) has been demonstrated to benefit patients with heart failure by reducing cardiac preload. This study aimed to compare the effectiveness of HFNC to NPPV for preventing extubation failure in patients with heart failure. This 3-year retrospective and single-center cohort study included patients with heart failure with left ventricular ejection fraction